Clinical and genetic risk factors for the development of laboratory resistance while taking acetylsalicylic acid in patients after atherothrombotic ischemic stroke

Key Points

• Laboratory resistance was observed in patients after atherothrombotic ischemic stroke, indicating genetic and clinical influences.
• The analysis presented findings derived from clinical evaluations and genetics, highlighting potential interactions.
• Risk factors for laboratory resistance were identified from patients under acetylsalicylic acid therapy post-stroke, emphasizing the role of both clinical and genetic aspects.
• Understanding these risk factors could enhance patient management strategies and tailor therapies for those at risk of laboratory resistance.